You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma

Article metrics

Article menu

Download PDFPDF

XML
Research Article
Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma

 

Online download statistics by month:

Online download statistics by month: December 2019 to June 2025

AbstractFullPdf
Dec 2019330
Jan 202013134
Feb 202028284
Mar 202046468
Apr 202058583
May 202038383
Jun 2020343410
Jul 2020303011
Aug 2020333315
Sep 2020858524
Oct 2020333321
Nov 2020272712
Dec 2020313112
Jan 2021393818
Feb 2021393914
Mar 202127277
Apr 2021484819
May 2021262626
Jun 2021323217
Jul 2021252511
Aug 2021313112
Sep 2021242415
Oct 2021303025
Nov 2021323219
Dec 202126269
Jan 202225288
Feb 2022232825
Mar 2022515311
Apr 2022323414
May 2022434419
Jun 2022343820
Jul 202233369
Aug 2022373710
Sep 2022535518
Oct 2022434513
Nov 2022262614
Dec 202238388
Jan 202342429
Feb 2023333410
Mar 202328297
Apr 2023313114
May 2023383810
Jun 202341414
Jul 2023373818
Aug 2023404110
Sep 2023474813
Oct 2023515113
Nov 2023565613
Dec 2023454515
Jan 2024262810
Feb 202433338
Mar 2024494915
Apr 2024666718
May 2024464712
Jun 2024555622
Jul 2024565612
Aug 2024363812
Sep 2024424314
Oct 2024626220
Nov 2024313316
Dec 2024484811
Jan 2025535415
Feb 202511211213
Mar 2025585821
Apr 2025616113
May 2025444514
Jun 2025414116
Total26842724886